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Introduction
Follicular fluid (FF) is an important component in the growth and development of the follicle. Therefore, changes in FF will influence the developing oocyte (Hennet & Combelles 2012) . FF consists of many substances, such as hormones, immune cells, cytokines, enzymes, anticoagulants, electrolytes, reactive oxygen species, lipids, cholesterol and antioxidants (Hennet & Combelles 2012 , Nagy et al. 2015 , Basuino & Silveira 2016 .
Endometriosis is a disorder characterized by the presence and growth of endometrial tissue outside the uterine cavity (Kennedy et al. 2005) . The most accepted theory on the origin of endometriosis is Sampson's theory of retrograde menstruation (Sampson 1927 , Izumi et al. 2018 . Research has demonstrated retrograde menstruation in most menstruating women (Ahn et al. 2015) . However, additional factors are essential to allow implantation and proliferation of endometrial cells and the development of endometriosis since clinical detected endometriosis only affects up to 10% of women in the reproductive age. In short, the clearance of endometrial debris in the peritoneal cavity is decreased in women with endometriosis, due to defective natural killer (NK) cell function, decreased phagocytosis by macrophages and induction of regulatory T cells (Zhang et al. 2018) .
Together, these factors may contribute to the tolerance of endometrial cells in the peritoneal cavity.
The peritoneal fluid (PF) in women with endometriosis is also marked by increased inflammation, including increased concentrations of leukocytes and cytokines secreted by ectopic endometrial cells and infiltrating immune cells. This promotes endometrial cell proliferation, endometrial cell adhesion and angiogenesis (Zhang et al. 2018) . Changes of the immune response detected in the peritoneal cavity can also be seen in uterine endometrial tissue, peripheral blood and FF (Zhang et al. 2018) .
The immunological profile of FF in patients with endometriosis could be a reflection of the immunological changes in the systemic circulation or alternatively a reflection of local inflammation due to endometriosis lesions in the ovary or peritoneal cavity (de Barros et al. 2017) . Furthermore, FF is a contributor to the PF at ovulation (Bahtiyar et al. 1998) . Interestingly, FF was found to stimulate the proliferation of ectopic endometrial cells in vitro and therefore repetitive exposure to FF during ovulation may be involved in the enhancement of peritoneal endometriosis (Bahtiyar et al. 1998) . Lower fecundity in women with endometriosis is attributed to anatomic alterations such as adhesions leading to disturbed folliculogenesis and ovum pick-up mechanisms (Somigliana et al. 2017) . Also involved in the lower fecundity in endometriosis is the trafficking of leukocyte subsets to the eutopic endometrium due to inflammatory changes. The specific chemokines that direct their migration and the inflammatory changes could have detrimental effects on endometrial receptivity, possibly via progesterone resistance and changes in endometrial gene expression (Lessey et al. 2013) . Our hypothesis is that the altered systemic and local peritoneal immune profile in endometriosis patients has its effects on the endometrium/decidua in the uterus. And furthermore on FF surrounding the maturing oocyte which both might lead to a reduced fecundity independent of the anatomical changes such as adhesions.
The aim of this narrative review is to summarize literature on the most prominent immune cells in the FF in the general infertile population and in patients with endometriosis. The key points relevant to FF immune cells and cytokines in reproductive outcomes and endometriosis that emerge from this review are listed in Box 1.
Methods
A comprehensive literature search was performed in the PubMed database for published literature on FF immune content, FF functions and FF composition in patients with and without endometriosis. We undertook a search on all literature published between 1990 and March 2019. English was used as language restriction. Relevant articles were identified by searching for (combinations of) search terms such as FF, endometriosis, cytokine, immunology, interleukin, T cell, B cell, lymphocyte, macrophage, antigen-presenting cell and NK cell. Additional studies were identified by analysis of reference lists. Data from studies were analyzed, interpreted and are presented in this review.
Results

Human FF
In antral follicles the oocyte undergoes a process of growth and maturation, to reach the optimal maturation stage for fertilization. This process occurs through a dynamic relationship between the oocyte within the antral follicle, consisting of granulosa and theca cells separated by the basement membrane ( Fig. 1) (Hennet & Combelles 2012) . During follicle growth an antrum is formed and filled with FF. FF is a combined product of those blood plasma constituents that cross the blood follicular barrier, and the granulosa and thecal cells' secretory activity (Gosden et al. 1988 ). The follicular microenvironment in which the oocyte matures is also influenced by the oocyte itself, through gap junctional communication and secreted factors within the oocyte-cumulus complex (Gilcrist et al. 2008) . FF consists of hormones, immune cells, cytokines, enzymes, anticoagulants, electrolytes, reactive oxygen species, lipids, cholesterol and antioxidants. Likely, immune cells secrete products in the FF as well ( Fig. 1 ) (Hennet & Combelles 2012 , Nagy et al. 2015 , Basuino & Silveira 2016 .
The composition of FF varies throughout the phases of follicular development (Baskind et al. 2014) . It is postulated that during the follicular phase, the basement membrane is intact, thereby preventing exchange from the theca cell compartment to the avascular granulosa cell compartment (Duffy et al. 2019) . When the luteal surge occurs, the basement membrane ruptures, causing vascular changes within the follicle resulting in invasion of capillaries with influx of various cells into the FF (Baskind et al. 2014) . The phases of follicular development are therefore relevant when reviewing FF composition and function. However, literature on FF composition does not always report these phases. Furthermore, hyper-stimulation in ART alters FF contents as well. Using immunohistochemical analysis, it has been shown for example that levels of CD45 + leucocytes were significantly higher in FF from stimulated IVF compared to FF from natural cycle IVF (Kollmann et al. 2017) . When using flow cytometry to further characterize 
Box 1 Key features of FF immune cells and cytokines
• Human FF is an important factor present in every stage of conception • High levels of CD56 bright CD16 − NK cells in FF are associated with good reproductive outcomes • High levels of CD56 dim CD16 + NK cells in FF are associated with adverse reproductive events • sHLA-G levels in FF are not a marker for good-quality oocytes • High levels of IL1B in FF are associated with good fertilization rates • Elevated levels of IL12 in FF are detrimental to reproductive success in IVF • In patients with endometriosis, NK cell levels in FF are higher compared to controls • In patients with endometriosis, CD14 + macrophages/ monocytes levels in FF are higher compared to controls • In patients with endometriosis, IL6, IL8 and IL12 levels in FF are higher compared to controls the difference in CD45 + cells, no statistically significant differences were found in percentages of CD3 + , CD4 + , CD8 + and CD19 + cells, showing that it is not a subsetspecific increase (Kollmann et al. 2017) .
Immunological substances in human FF
FF consists of several immune cell subsets and cytokines.
Within FF immune cells such as NK cells, T-and B lymphocytes, dendritic cells (DCs) and macrophages have been found (Lachapelle et al. 1996 , Takaya et al. 1997 , Fainaru et al. 2012 ). In general, most studies use pre-ovulatory FF collected during IVF cycles with ovarian hyperstimulation for their analyses. The origin of FF leukocytes and cytokines in general is hard to determine, due to (some) contamination of the aspirate with blood during oocyte harvesting, collected after the induced LH surge or hCG injection. One study has examined leukocytes and erythrocyte levels within peripheral blood and follicular aspirate in patients with male factor infertility undergoing controlled ovarian hyperstimulation. This study reported that leukocytes appear independently of erythrocytes in follicular fluid, which indicates that active infiltration into FF takes place. It is unknown whether this infiltration is before or after the hCG administration which induces the final maturation of the oocyte in IVF (Smith et al. 2005) . In the following sections of this review, we will summarize the literature on immune cells -and the interaction between these cells and cytokines -in FF and in endometriosis-related alterations in FF.
NK cells in human FF
NK cell subsets are distinguished phenotypically and functionally by their CD56 and CD16 surface antigen expression (Fainaru et al. 2011) . The CD56 dim CD16 + and CD56 bright CD16 + NK cell subsets are cytotoxic, whereas the CD56 bright CD16 − NK cell subset has a more immune regulatory and pro-angiogenic function. One study measured levels of the pro-angiogenic (CD56 bright CD16 − ) and cytotoxic (CD56 dim CD16 + ) NK cells in the FF of antral follicles (<10 mm), collected 38 h after hCG injection in patients with PCOS (n = 8) and patients with a contraindication for hormonal therapy (n = 2) (endometrial and breast carcinomas) in the context of in vitro maturation (IVM). This was compared with levels of NK cells in the FF of mature follicles (>18 mm), collected 34 h after hCG injection during IVF treatment in patients with an infertility diagnosis (male, unexplained, tubal). The distribution of NK cell subpopulations in FF derived from an antral follicle of IVM patients revealed a predominance of cytotoxic CD56 dim CD16 + and CD56 bright CD16 + NK cell in the antral follicle compared to mature follicles (Fainaru et al. 2011) . The infertility diagnoses in each group (IVM versus IVF) were different, which might introduce a difference in the reported distribution of NK cell subpopulations. This could be due to an altered immune profile of the various diagnostic categories of the patients instead of the maturity of the follicles. Krizan and colleagues reported that the relative distribution of CD56 bright CD16 − immune regulatory NK cells in FF was significantly higher in patients after a successful IVF treatment resulting in a pregnancy, compared with a negative outcome (Krizan et al. 2009 ). On the other hand, higher levels of the CD56 dim CD16 + cytotoxic NK cells in FF from IVF patients with unexplained infertility compared with a control group, consisting of patients with male factor infertility, are associated with diminished fertilization rates. The balance between angiogenic and cytotoxic NK cell subsets in the developing follicle might contribute to maturation of the cumulus-oocyte complex and the final goal of achieving a pregnancy. However, the functional role of these cells was not determined (Lukassen et al. 2003) .
Macrophages in human FF
The presence of macrophages in FF, obtained after hCG injection during IVF cycles with ovarian hyperstimulation, are described in several studies (Lachapelle et al. 1996 , Smith et al. 2005 . Macrophages can be classified into different functional subsets, with specific roles in vascularization, tissue remodeling and inflammation (Wu et al. 2004 , Sica & Mantovani 2012 . However, only total macrophage fractions have been studied and to our knowledge macrophage subsets in FF have not yet been analyzed in humans. Brannstrom et al. (1994) found elevated macrophage density in the infiltrate of the thecal layer of the human follicle wall immediately after the LH surge. Takaya et al. (1997) analyzed macrophage levels in normal human ovulating cycles and reported lower macrophage infiltration in the stroma and theca cell layer in developing follicles as compared to corpora lutea. Wu et al. (2004) proposed that ovarian macrophages stimulate theca and granulosa cell proliferation, follicle growth and suppress follicular apoptosis, by secreting growth factors and cytokines. Ovarian macrophages secrete growth factors like epidermal growth factor (EGF) and insulin-like growth factors (IGFs), granulocyte macrophage-colony stimulating factors (GM-CSF) as well as cytokines such as IL1B, IL1, IL6, IL10, IL12, IFNa and TNFa (Wu et al. 2004) . Cytokine profiles in FF will be further discussed in 'Cytokines in human FF'. To our knowledge, there are no studies describing the macrophage levels in human FF in the different follicular phases despite their presumed relevance in cytokine production.
Human leukocyte antigen (HLA)-G in human FF
HLA-G is a non-classical HLA-class Ib molecule from the major histocompatibility complex.
Despite the presence of soluble HLA-G1 (sHLA-G) and sHLA-G5 in FF, the role of intrafollicular sHLA-G molecules remains largely unknown (Shaikly et al. 2008 , Jee et al. 2011 , Ouji-Sageshima et al. 2016 . Granulosa cells are identified as the primary source of sHLA-G in FF, but sHLA-G could also emanate from peripheral circulation, possibly during oocyte harvesting (Shaikly et al. 2008 , Rizzo et al. 2009 ). Several studies have investigated HLA-G as a marker for oocyte quality and implantation potential. Studies showed an inverse correlation between sHLA-G levels in FF and oocyte quality, reflected by fertilization rate, but no association with successful pregnancy (Jee et al. 2011 , Ouji-Sageshima et al. 2016 .
T and B lymphocytes and subpopulations in human FF
The presence of T and B subsets in FF has been described in several heterogeneous groups of infertile patients with different indications and comparing stimulated IVF with natural cycle IVF using markers as CD3, CD4, CD8, CD14, CD15, CD19, CD20, CD27, CD45 and CD57 (Hill et al. 1989 , Lachapelle et al. 1996 , Vujisic et al. 2004 , Wu et al. 2007 , Qin et al. 2016 , Kollmann et al. 2017 ). However, the function of these cells in FF remains largely unknown. As CD4 + T cells can be divided in Th1, Th2, Th17 and Treg subsets (Guerin et al. 2009 , Wan et al. 2010 , which all have their specific function, future studies analyzing these subsets in FF in more detail related to the outcome of IVF are needed.
Cytokines in human FF
Cytokines are small-molecular-weight glycoproteins that act as intercellular mediators across various immune effector cells, ovarian somatic cells and the oocyte (Vujisic & Zidovec 2005 , Baskind et al. 2014 ). The following cytokines have been found in FF: IL1a and IL1B, IL2, IL6, IL8, IL10, IL11, IL12, IL13, IL17A, IL18, IL23, granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), TNFa, vascular endothelial growth factor (VEGF), EGF, platelet-derived growth factor (PDGF), IGF, leukemia inhibitory factor (LIF), fibroblast growth factor (FGF), RANTES (CCL5) and stem cell factor (SCF) (Vujisic & Zidovec 2005 , Sabbaghi et al. 2014 ). Many cytokines have been found in FF, in the current review, we have focused on those cytokines which are mainly reported in FF of patients with endometriosis. Below we briefly describe these cytokines.
TNFa is a pro-inflammatory cytokine released by macrophages and its production can be induced by VEGF. It has a role in proliferation of granulosa cells and enhances its IL8 secretion (Kilic et al. 2007 , Opøien et al. 2013 ). TNFa level is significantly higher in FF associated with poor quality oocytes and embryos (Wunder et al. 2006) .
VEGF is a mediator that helps folliculogenesis and formation of the corpus luteum by stimulating ovarian angiogenesis, and it can be secreted by granulosa cells. Intrafollicular VEGF concentrations have no predictive value to evaluate IVF treatment outcome (Kilic et al. 2007) .
IL1B is a pro-inflammatory cytokine that stimulates proliferation and activation of T and B cells, this cytokine is mainly produced by macrophages and monocytes. In the thecal cell layer of the human ovarian follicle, the presence of IL1B has been described, and an increase of intrafollicular IL1B at the time of ovulation is seen (Brannstrom et al. 1994 ). Furthermore, IL1B induces granulosa cell and theca cell IL6 and IL8 production (Baskind et al. 2014) . In IVF patients, high levels of IL1B in FF were associated with good fertilization rates (Zollner et al. 2013 ). There is no correlation between FF IL1B levels and embryo morphology or pregnancy rates. Also, IL1B levels show no variation in FF concentrations during follicular development.
IL6 is not only produced by macrophages, Th1 cells and B cells, but also by fibroblasts and endothelial cells (Cameron & Kelvin 2003) . The expression of IL6 has been described in the granulosa cells of the follicle, the corpus luteum, ovarian theca cells, the endometrium and IL6 in FF is significantly increased in the peri-ovulatory phase as compared to the follicular phase Baskind et al. (2014) . Contradictory results exist on the possible effects of IL6 on IVF outcome. IL6 levels in FF were significantly higher in pregnant compared to non-pregnant IVF treated women (Bedaiwy et al. 2007) . In contrast to these findings, another study reported detrimental effects of elevated FF IL6 levels on the outcome of IVF. Patients with IL6 levels in FF lower than the median were twice as likely to achieve clinical pregnancy as patients with higher IL6 levels (Altun et al. 2011 ). Both studies included comparable patients, but Bedaiwy et al. (2007) only performed univariate analysis, whereas Altun et al.
(2011) did multivariate analysis including duration of COH, FF IL6 level and the number of embryos transferred, which could explain different results. The latter study used group medians for statistical analysis, but in the final statistical model included a FF IL6 cut-off level of <4.0 pg/mL as the independent variable. IL6 cutoffs could possibly be more reliable.
IL8 is a pro-inflammatory cytokine secreted by granulosa cells and involved in the recruitment and activation of neutrophils as well as cell proliferation and angiogenesis, and with that likely important in folliculogenesis, ovulation and repair of the ruptured follicle (Vujisic & Zidovec 2005) . In FF, significantly higher levels of IL8 were found in the pre-ovulatory phase and LH surge, as compared to the follicular phase, both in natural cycles and stimulated cycles (Baskind et al. 2014) . Therefore, it is thought that granulosa cell and theca cell IL8 secretion is associated with follicle growth, oocyte maturation and ovulation, rather than being solely the result of hormonal stimulation (Runesson et al. 2000) . IL8 seems to vary inversely with IL10, IL12 and TNFa, indicating that immune cells may interact with granulosa cell function (Opøien et al. 2013) . IL8 levels in FF are not associated with fertilization and implantation rates or IVF outcome (Gazvani et al. 2000) .
IL12 is a pro-inflammatory cytokine that regulates the immune system as an inductor of Th1 response and regulator of biological activities of T cells and NK cells (Gazvani et al. 2000) . IL12 levels are significantly higher in FF of women who failed to become pregnant with IVF (Gazvani et al. 2000 , Bedaiwy et al. 2007 , Altun et al. 2011 . High levels of IL12 may represent an increased inflammatory state of the maternal immune system and with that lower pregnancy success.
RANTES (CCL5) is a chemokine, widely expressed in tissue and a potent monocyte, macrophage, T lymphocyte and eosinophil attractant. The regulation of RANTES can reflect local modulation of the immune system together with MCP-1 (Xu et al. 2006) .
Many studies have focused on the analysis of the individual number of cytokines, despite the fact that these mediators are known to operate in networks rather than in isolation, exhibiting features such as pleiotropism, synergy, antagonism and functional redundancy. It follows that the effect of any given cytokine is therefore not just dependent upon its absolute concentration, but rather on a balance between its own effects and those induced by other local mediators, including other cytokines (Field et al. 2014) .
Dendritic cells in human FF
Dendritic cells (DC) initiate and coordinate innate and adaptive immune responses. After maturation, DCs migrate into lymph nodes, where interaction with antigen-specific T cells takes place to evoke an immune response (Fainaru et al. 2012) . Following activation, DCs produce cytokines such as IL6, IL23 and TNFa. DCs function as a bridge between pathogen recognition and effector cells of both the innate and adaptive immunity (Sallusto 2013) . DCs are a significant part of the bone marrow-derived leukocytes in the FF of the maturing oocyte immediately before ovulation, making up to 15% of the FF content of these cells (Fainaru et al. 2012) . In patients undergoing IVF treatment DCs are present in pre-ovulatory FF and are characterized by expression of CD11c and HLA-DR. DC maturation correlates positively with the ovarian response to gonadotropins, but correlations between immune parameters in FF and oocyte quality, pregnancy outcomes are not reported (Fainaru et al. 2012 , Zhang et al. 2017a .
Alterations of immune cells in patients with endometriosis
Our hypothesis is that the altered systemic and peritoneal immune profile in endometriosis patients has its effects on the endometrium/decidua in the uterus, as well as on FF surrounding the maturing oocyte. Both could possibly lead to a reduced fecundity due to an imbalanced immune profile, where a balanced profile is required for the maturing cumulus-oocyte complex in the follicles (Fig. 2) .
NK cells in FF of patients with endometriosis
In patients with superficial peritoneal endometriosis (stage I/II) undergoing IVF treatment, higher levels of NK cells have been reported in FF compared to patients without endometriosis. Approximately 20% of CD56 + NK cells expressed CD16, which indicates that the increase in NK cells was caused predominantly by the proangiogenic NK subset (CD16 -) (Lachapelle et al. 1996) . Endometriosis is an angiogenesis dependent condition; thus, it is not surprising that there is an abundance of proangiogenic NK cells. In light of these results, modifications in the distribution of immune cell populations in the FF of patients with endometriosis likely influence the follicular environment and could subsequently influence folliculogenesis and cumulus-oocyte maturation. The cellular immune dysregulation in human ovaries could be a factor altering fertility. The presence of CD56 + CD16pro-angiogenic NK cells has been associated with successful implantation, favorable IVF outcome, spiral artery remodeling and placental maturation (Fainaru et al. 2010) . However, higher levels of these proangiogenic NK cells in FF of endometriosis patients are likely related to endometriosis itself and any positive effects on placentation will be too small to compensate for the higher inflammatory state in the endometrium. The pro-angiogenic NK cells in FF released during ovulation could create a certain peritoneal environment stimulating the development of peritoneal endometriosis, which in turn creates an even more inflammatory environment and with that compromised fecundity.
Macrophages in FF of patients with endometriosis
Macrophages are among the first immune cells to be recruited when endometrial fragments enter the peritoneal cavity. Compared to women without endometriosis, in women with endometriosis, the number of peritoneal macrophages, the activation status and the concentration of inflammatory cytokines (i.e. IL1B, IL6, TNFa) secreted by these macrophages are elevated (Wunder et al. 2006) . By secreting these proinflammatory cytokines, macrophages may promote the establishment of an inflammatory environment favorable for endometriosis development.
In patients with endometriosis (stage I/II), compared with groups of idiopathic infertility and tubal factor, flow cytometric evaluation in FF revealed higher levels of CD14 + macrophages/monocytes which could lead to altered cytokine levels, leading to dysregulation of folliculogenesis and thereby impacting fertility (Lachapelle et al. 1996) . These CD14 + cells were not further characterized into macrophage or monocyte subsets.
Many macrophage-derived cytokines, such as IL1B and IL6, are increased in the FF of patients with endometriosis, indicating strong macrophage activity in FF, which may contribute to the pathogenesis of endometriosis (Pellicer et al. 1998 , Tsudo et al. 2000 , Wu et al. 2004 .
Although higher levels of CD14 + macrophages/ monocytes in FF of endometriosis patients have been found, to our knowledge, these levels have not been further characterized into specific subsets. Therefore, it is difficult to interpret the exact role of these higher FF levels of macrophages in endometriosis and its associated fertility problems. More research is needed to determine the differences in peritoneal and FF macrophage subsets and the effects on folliculogenesis, maturation of the oocyte or oocyte quality and the involvement in the pathophysiology of endometriosis.
HLA-G in FF of patients with endometriosis
sHLA-G has been demonstrated to induce apoptosis of activated CD8 + T cells and to modulate the NK cell and cytotoxic T lymphocyte responses, whereas membranebound HLA-G proteins have been shown to inhibit both natural killer cell and T cell-mediated cytolysis, to suppress proliferation of CD4 + T lymphocytes and to induce a Th2 cytokine profile (Eidukaite & Tamosiunas 2008) . In endometriosis, HLA-G was found in ectopic endometrial cells in the peritoneal cavity in women which is postulated to aid in their escape from immunosurveillance, due to their role in the protection against NK cell-mediated lysis (Barrier et al. 2006 , Kawashima et al. 2009 , Rached et al. 2019 .
Eidukaite and Tamosiunas compared PF sHLA-G concentrations between endometriosis patients and controls. sHLA-G was found in all groups investigated without significant differences in concentrations (Eidukaite & Tamosiunas 2008) . Rached et al. assessed sHLA-G levels in serum and PF in women with and without endometriosis. Higher concentration of sHLA-G in serum but not in the PF were observed in women with advanced endometriosis compared to the control group (Rached et al. 2019) . Binding of the sHLA-G to inhibitory receptors on immune cells might explain the non-significant lower concentrations in sHLA-G available in PF between women with and without endometriosis (Rached et al. 2019) . Mach et al. compared the blood sera among patients with ovarian cancer, ovarian endometrioma and deep endometriosis. The HLA-G concentration levels in the patients with deep endometriosis were comparable to those found in the patients with ovarian cancer, in contrast to significantly lower levels found in patients with ovarian endometrioma (Mach et al. 2010) . HLA-G was furthermore found in ectopic endometrial cells in the peritoneal cavity in women which is postulated to aid in their escape from immunosurveillance due to their role in the protection against NK cell-mediated lysis (Barrier et al. 2006 , Kawashima et al. 2009 , Rached et al. 2019 . To our knowledge, no studies have been published yet on sHLA-G levels in FF of patients with endometriosis.
T and B cells in FF of patients with endometriosis
Changes in the adaptive immune responses (T and B lymphocytes) have been described in the endometrium, PF and peripheral blood of patients with endometriosis, compared to women without this disorder (Podgaec et al. 2012 , Olkowska-Truchanowicz et al. 2013 , Ahn et al. 2015 . Studies showed a balance toward Th2 cytokines in peripheral blood and PF of women with endometriosis (Hsu et al. 1997) . This shift toward a Th2 immune response was confirmed by Podgaec et al., who found elevated IL4, IL10 and IFN-gamma levels in the PF of patients with endometriosis compared to those without endometriosis (Podgaec et al. 2007) .
A subset of cells which is involved in the immune processes in endometriosis are regulatory T cells (Tregs). These are specialized T lymphocytes with R51 immunosuppressive properties (Guerin et al. 2009 , de Barros et al. 2017 . Several studies have found Treg cell concentrations to be higher in the peripheral blood, PF and eutopic endometrium in patients with endometriosis, compared to patients without endometriosis (Podgaec et al. 2012 , Olkowska-Truchanowicz et al. 2013 .
Although it seems logical that the higher levels of Treg cells are involved in the immune tolerance of the endometriotic lesions, this has not been fully elucidated yet.
Similar to other specific cell subsets of T and B cells, there is not much known about Treg cells in FF. One study showed that patients with endometriosis have higher levels of B cells, and comparable levels of T cells in FF compared to groups with other infertility causes (Lachapelle et al. 1996) . However, to our knowledge, no further analysis of T and B cell subsets in FF have been done in patients with endometriosis. Therefore, no conclusions can be made yet about possible correlations between T and B cells in FF, endometriosis and the effect on folliculogenesis, oocyte maturation and infertility. Singh et al. (2016) reported an increase in the levels of pro-inflammatory (IL1B, TNFa, IL2, IL8, IL12) and anti-inflammatory (IL4, IL6 and IL10) cytokines in FF of patients with endometriosis (grade III/IV) undergoing IVF as compared with patients with tubal factor infertility (Box 2). The percentage of mature oocyte and goodquality embryos was significantly lower in endometriosis as compared with controls. Part of these findings were confirmed by Choi et al. (2015) who also reported higher levels of IL6, IL8, TNFa and IL1B in FF of endometriosis patients (Choi et al. 2015 ). Whereas Falconer et al. (2009 found lower levels of IL10 in FF of endometriosis patients (Falconer et al. 2009 ). Pellicer et al. (1998 reported significantly higher IL6 and higher, but not statistically significant, IL1B levels in FF of patients with endometriosis (grade III/IV) undergoing IVF as compared with patients with tubal factor infertility. Zhang et al. also analyzed cytokines in women with severe endometriosis (grade III/IV), although they did not find a difference in these cytokines between the control and grade III/IV endometriosis patients, IL23 levels in FF were significantly higher in patients with stage III/IV endometriosis compared to stage I/II (Zhang et al. 2017b) .
Cytokines in FF of patients with endometriosis
The results of the study by Pellicer et al. were confirmed in the study of Wu et al. (2017) in natural cycle IVF in women with moderate-to-severe endometriosis. On the other hand, Opøien et al. (2013) found no difference in cytokine levels (IL1B, IL6, IL8, IL10, IL12 and TNFa) in the leading follicle adjacent to endometriomas. These results suggest that intra-ovarian endometriosis itself is not associated with local inflammatory reaction.
Furthermore, Kilic et al. (2007) compared VEGF and TNFa concentrations in FF of patients with endometriosis and unexplained infertility and reported a significant higher concentration VEGF in the endometriosis group but no difference in TNFa concentration between the two groups. The levels of RANTES and MCP-1 (both chemokines) have also been analyzed in FF of endometriosis patients, Xu et al. (2006) have shown higher levels of RANTES and lower levels of MCP-1 in FF of women with endometriosis compared with tubal infertility (Xu et al. 2006) .
These altered levels of cytokines, including chemokines, could very well be a result of the increased inflammatory state in endometriosis. Moreover, these levels in turn could attract more immune cells into the follicle or into the peritoneal cavity after ovulation. Differences in patient characteristics and methods used can explain the sometimes contradicting results. Although both pro-and anti-inflammatory cytokines have been found higher in FF of endometriosis patients, the balance of these elevated cytokines indicated a pro-inflammatory environment, which confirms the inflammatory character of endometriosis.
Altered cytokine profiles in the FF of patients with endometriosis may play a significant role in an altered folliculogenesis, oocyte maturation, oocyte quality, ovulation and fecundity associated with endometriosis. Possibly, the higher levels of FF cytokines are produced by the granulosa cells or the FF immune cells which might be more activated in endometriosis. However, the activity of these FF immune cells is yet to be analyzed in endometriosis patients (Wu et al. 2017 
Dendritic cells in FF of patients with endometriosis
In mouse models DCs have been shown to be important in the development of endometriosis. In humans the role of DCs in endometriosis is largely unknown (Pencovich et al. 2014 , Stanic et al. 2014 . Fainaru et al. (2012) described in one case an unilateral endometrioma which was associated with complete absence of DCs, contrary to a follicle of the contralateral ovary, where an abundance of DCs was seen. Another study reported lower levels of HLA-DR + , CD11c + CD123 + DCs in PF of patients with endometriosis compared to controls with no endometriosis; however, this did not reach statistical significance (Tariverdian et al. 2009 ). Further research is necessary on DCs presence and function in the FF of endometrsiosis patients to determine the effect on folliculogenesis, oocyte maturation, quality and fertility potential.
Conclusion
We hypothesized that the altered immune profile in endometriosis patients has its effects not only on the endometrium/decidua in the uterus, but also on FF surrounding the maturing oocyte both possibly leading to a reduced fecundity (Fig. 2) . FF represents the microenvironment for the oocyte to develop optimally. FF is composed of many substances including immune cells and cytokines, all of which are likely to play a crucial role in maturing of the oocyte and implantation of the resulting embryo. The physiological role of the immune cells and cytokines in FF in the normal follicle is not yet determined. Therefore, the exact role and differences of FF in women with immune-mediated diseases such as endometriosis remain unknown. In the PF, peripheral blood and endometrium of patients with endometriosis, multiple alterations have been found that possibly contribute to the establishment and development of the disease, such as impaired NK cell activity, reduced phagocytosis capacity of macrophages and elevated Treg concentrations. Increased quantities of peritoneal and follicular macrophages are held accountable for the secretion of many cytokines, which in turn might alter FF, thereby possibly influencing follicle maturation, oocyte development and quality. Although many studies have addressed FF macrophage, NK cell and cytokine quantity, activity and alterations in patients with endometriosis and compared to patients without endometriosis, the results are not conclusive. The effect of follicle fluid, released at ovulation, to the peritoneal cavity as a synergistic factor in the development of endometriosis also demand further exploration. While decidual T cells seem to play an important role in achieving a normal pregnancy, with an important role for Tregs, no studies so far have been undertaken to analyze these T cells in FF of women with endometriosis. Future studies in this field might give us more insight in the role of immune cells and cytokines in the mechanism of and the effects on the folliculogenesis, oocyte maturation, oocyte quality, ovulation and fecundity in patients with endometriosis. This knowledge might have a great impact in reducing infertility in endometriosis, by interfering with the immune cell and cytokine balance in FF.
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